Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00135135
What this trial is testing

Therapy for Children With Neuroblastoma

Who this might be right for
Neuroblastoma
St. Jude Children's Research Hospital 23
Not applicableLooking for participantsNCT07285668
What this trial is testing

Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
University of Wisconsin, Madison 38
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Testing effectiveness (Phase 2)Study completedNCT02169791
What this trial is testing

Nonmyeloablative Haploidentical Transplant Followed by MLN9708

Who this might be right for
Acute LeukemiaChronic LeukemiaMyelodysplastic Syndrome+2 more
Northside Hospital, Inc. 29
Testing effectiveness (Phase 2)UnknownNCT01807468
What this trial is testing

Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaRhabdomyosarcoma+2 more
Samsung Medical Center 12
Not applicableStudy completedNCT06405815
What this trial is testing

A Radiomic Model for Risk of Local Recurrence and DFS for T3 and T4 Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer, Nonsmall Cell
Jinling Hospital, China 200
Not applicableEnded earlyNCT02439008
What this trial is testing

Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response

Who this might be right for
Carcinoma, HepatocellularColorectal NeoplasmsMelanoma+1 more
Centre Oscar Lambret 28
Testing effectiveness (Phase 2)Study completedNCT04733768
What this trial is testing

18F-PSMA-1007 PET/CT Imaging in Patients with Biochemically Recurrent or High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
University of Alberta 100
Large-scale testing (Phase 3)Looking for participantsNCT06509724
What this trial is testing

Comparison of Conventional and Hypofractionated IMRT in High-Risk Cervical Cancer Post-Radical Hysterectomy

Who this might be right for
Uterine Cervical Neoplasms
Samsung Medical Center 248
Large-scale testing (Phase 3)Study completedNCT00002596
What this trial is testing

Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorTesticular Germ Cell Tumor
Memorial Sloan Kettering Cancer Center 270
Early research (Phase 1)Ended earlyNCT00053950
What this trial is testing

Pyrazoloacridine and Stem Cell or Bone Marrow Transplantation in Treating Young Patients With High-Risk Neuroblastoma

Who this might be right for
Disseminated NeuroblastomaRecurrent Neuroblastoma
National Cancer Institute (NCI) 42
Not applicableStudy completedNCT00942760
What this trial is testing

Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas

Who this might be right for
Recurrent High Grade Gliomas
Dartmouth-Hitchcock Medical Center 12
Early research (Phase 1)Study completedNCT00877110
What this trial is testing

Anti-GD2 3F8 Antibody and Allogeneic Natural Killer Cells for High-Risk Neuroblastoma

Who this might be right for
NeuroblastomaBone Marrow, Sympathetic Nervous System
Memorial Sloan Kettering Cancer Center 71
Testing effectiveness (Phase 2)UnknownNCT00657982
What this trial is testing

Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sheba Medical Center 15
Not applicableLooking for participantsNCT07527689
What this trial is testing

Ultra-Hypofractionated vs Moderate Hypofractionated Radiotherapy for Regional Lymph Nodes in High Risk Breast Cancer

Who this might be right for
Breast Cancer
Ruijin Hospital 1,950
Not applicableWithdrawnNCT01811810
What this trial is testing

Proton Therapy for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine
Not applicableUnknownNCT03914820
What this trial is testing

Prophylactic Surgery Plus HIPEC With CO2 in Patients Affected by Colorectal Carcinoma. CHECK Study.

Who this might be right for
Colorectal Neoplasms
Mario Negri Institute for Pharmacological Research 330
Testing effectiveness (Phase 2)UnknownNCT04650711
What this trial is testing

Immunohistochemical Staining of p16 for the Screening of Cervical Cancer

Who this might be right for
Cervical Cancer Screeningp16 ProteinCytology+4 more
Lei Li 250
Not applicableNot Yet RecruitingNCT06541171
What this trial is testing

A New Fast DWI-based MR Protocol for Surveillance in Patients With a High Risk of Ovarian Cancer Recurrence During PARP-inhibitors Maintenance to Enhance Secondary Cytoreduction Results

Who this might be right for
Ovarian CancerRecurrent Ovarian Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 220
Testing effectiveness (Phase 2)Ended earlyNCT00074334
What this trial is testing

TP-38 Toxin in Treating Young Patients With Recurrent or Progressive Supratentorial High-Grade Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 3
Next Page